Credit Suisse’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $1.25M | Sell |
36,987
-259
| -0.7% | -$8.75K | ﹤0.01% | 2127 |
|
2023
Q4 | $1.17M | Sell |
37,246
-7,607
| -17% | -$240K | ﹤0.01% | 2230 |
|
2023
Q3 | $1.15M | Sell |
44,853
-16,693
| -27% | -$427K | ﹤0.01% | 2207 |
|
2023
Q2 | $1.77M | Buy |
61,546
+18,571
| +43% | +$533K | ﹤0.01% | 1981 |
|
2023
Q1 | $1.03M | Buy |
42,975
+5,451
| +15% | +$131K | ﹤0.01% | 2293 |
|
2022
Q4 | $636K | Buy |
37,524
+4,437
| +13% | +$75.3K | ﹤0.01% | 2614 |
|
2022
Q3 | $490K | Buy |
33,087
+8,309
| +34% | +$123K | ﹤0.01% | 2772 |
|
2022
Q2 | $390K | Sell |
24,778
-863
| -3% | -$13.6K | ﹤0.01% | 2984 |
|
2022
Q1 | $692K | Sell |
25,641
-363
| -1% | -$9.8K | ﹤0.01% | 2768 |
|
2021
Q4 | $963K | Buy |
26,004
+1,433
| +6% | +$53.1K | ﹤0.01% | 2611 |
|
2021
Q3 | $1.17M | Buy |
24,571
+12,788
| +109% | +$611K | ﹤0.01% | 2473 |
|
2021
Q2 | $398K | Sell |
11,783
-2,919
| -20% | -$98.6K | ﹤0.01% | 3150 |
|
2021
Q1 | $607K | Sell |
14,702
-34,829
| -70% | -$1.44M | ﹤0.01% | 2846 |
|
2020
Q4 | $2.15M | Sell |
49,531
-26,030
| -34% | -$1.13M | ﹤0.01% | 2082 |
|
2020
Q3 | $3.24M | Buy |
75,561
+59,346
| +366% | +$2.54M | ﹤0.01% | 1519 |
|
2020
Q2 | $757K | Sell |
16,215
-3,144
| -16% | -$147K | ﹤0.01% | 2471 |
|
2020
Q1 | $263K | Sell |
19,359
-39,644
| -67% | -$539K | ﹤0.01% | 2901 |
|
2019
Q4 | $641K | Buy |
+59,003
| New | +$641K | ﹤0.01% | 2781 |
|
2017
Q1 | – | Sell |
-1,972
| Closed | -$29K | – | 3416 |
|
2016
Q4 | $29K | Sell |
1,972
-9,999
| -84% | -$147K | ﹤0.01% | 3690 |
|
2016
Q3 | $207K | Buy |
11,971
+3,388
| +39% | +$58.6K | ﹤0.01% | 3456 |
|
2016
Q2 | $270K | Buy |
8,583
+91
| +1% | +$2.86K | ﹤0.01% | 3439 |
|
2016
Q1 | $225K | Buy |
8,492
+2,243
| +36% | +$59.4K | ﹤0.01% | 3343 |
|
2015
Q4 | $275K | Buy |
+6,249
| New | +$275K | ﹤0.01% | 3506 |
|
2014
Q4 | – | Sell |
-7,860
| Closed | -$850K | – | 4184 |
|
2014
Q3 | $850K | Buy |
7,860
+5,997
| +322% | +$649K | ﹤0.01% | 2831 |
|
2014
Q2 | $226K | Buy |
1,863
+220
| +13% | +$26.7K | ﹤0.01% | 3859 |
|
2014
Q1 | $209K | Buy |
+1,643
| New | +$209K | ﹤0.01% | 3952 |
|